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Background: Streptococcus suis is a major problem in the swine industry causing meningitis, arthritis and
pericarditis in piglets. Pathogenesis of S. suis is poorly understood. We previously showed that introduction of a
3 kb genomic fragment from virulent serotype 2 strain 10 into a weakly virulent serotype 2 strain S735, generated a
hypervirulent isolate. The 3 kb genomic fragment contained two complete open reading frames (ORF) in an
operon-structure of which one ORF showed similarity to folylpolyglutamate synthetase, whereas the function of the
second ORF could not be predicted based on database searches for protein similarity.
Results: In this study we demonstrate that introduction of orf2 from strain 10 into strain S735 is sufficient to
dramatically increase the virulence of S735 in pigs. This increase in virulence could not be associated with changes in
pro-inflammatory responses of porcine blood mononucleated cells in response to S. suis in vitro. Sequence analysis
of the orf2-folC-operon of S. suis isolates 10 and S735 revealed an SNP in the −35 region of the putative promoter
sequence of the operon, as well as several SNPs resulting in amino acid substitutions in the ORF2 protein. Transcript
levels of orf2 and folC were significantly higher in the virulent strain 10 than in the weakly virulent strain S735 and
in vitro mutagenesis of the orf2 promoter confirmed that this was due to a SNP in the predicted −35 region upstream
of the orf2 promoter. In this study, we demonstrated that the stronger promoter was present in all virulent and highly
virulent S. suis isolates included in our study. This highlights a correlation between high orf2 expression and virulence.
Conversely, the weaker promoter was present in isolates known to be weakly pathogenic or non-pathogenic.
Conclusion: In summary, we demonstrate the importance of orf2 in the virulence of S. suis.
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Streptococcus suis is a zoonotic pathogen that is ubiqui-
tously present among swine populations in the pig indus-
try. Thirty-three capsular serotypes have been described to
date [1] of which serotypes 1, 2, 7, 9 and 14 are frequently
isolated from diseased pigs in Europe [2]. Strain virulence
differs between serotypes and even within a serotype: viru-
lent, avirulent and weakly virulent isolates have been iso-
lated based on the expression of virulence markers,
muramidase released protein (MRP) and extracellular fac-
tor (EF) [3] and suilysin [4,5].* Correspondence: astrid.degreeff@wur.nl
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unless otherwise stated.Nasopharyngeal carriage of S. suis in adult pigs is
asymptomatic, whereas in young piglets this increases
susceptibility to S. suis invasive disease, leading to menin-
gitis, arthritis and serositis, and high rates of mortality [5].
In Western countries humans occupationally exposed to
pigs or uncooked pork might also become infected by S.
suis although the incidence is very low [6]. Invasive S. suis
infection of humans gives similar clinical signs as in pigs;
patients often suffer from remaining deafness after reco-
very [6]. In Southeast Asia however, S. suis is considered
an emerging pathogen for humans, and is recognized as
leading cause of bacterial meningitis [7-10]. In Southeast
Asia, clinical signs of human infections with S. suis are re-
ported to be more severe compared to other parts of the
world, with patients developing toxic shock-like syndrome,
sepsis and meningitis [8].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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V[10]) was generated that causes severe toxic shock-like
syndrome in piglets after infection resulting in death
within 24 h post-infection [11]. S735-pCOM1-V[10] was
selected from a library of clones generated in a weakly
virulent serotype 2 isolate (S735), after transformation with
plasmid DNA isolated from around 30,000 pooled clones
carrying randomly cloned genomic DNA fragments from a
virulent serotype 2 isolate (strain 10). Isolates with in-
creased virulence were selected by infecting piglets with
strain S735 containing the plasmid library of genomic frag-
ments from strain 10. One prevalent clone isolated from
the infected piglets contained a 3 kb genomic fragment
from strain 10 designated V[10] and was demonstrated to
be hypervirulent in subsequent animal experiments. V[10]
contained an incomplete open reading frame (ORF),
followed by two genes (orf2 and folC) in an operon struc-
ture as well as a second incomplete ORF [11]. Assuming
that only the full-length ORFs could contribute to the
hypervirulence of this isolate, we further characterized the
orf2-folC-operon. The first ORF in the operon could not
be annotated and was designated orf2, the second ORF in
the operon showed homology to polyfolylpolyglutamate
synthase (folC) [11]. This operon was present in all S. suis
serotypes, including the parent strain S735. Strain S735
with low virulence, contained several single nucleotide
polymorphisms (SNP) in orf2-folC and the non-coding re-
gions compared to strain 10 [11].
In this study, we aimed to explain the increased viru-
lence of the strain containing the orf2-folC operon. We
demonstrate that overexpression of orf2 suffices to in-
crease the virulence, and that a SNP in the predicted −35
region upstream of the promoter of the operon is strongly
associated with virulence in S. suis isolates. Furthermore,
the stronger promoter was shown to be present in all viru-
lent or highly virulent S. suis isolates that were included in
our study, highlighting a correlation between high orf2 ex-
pression and virulence.
Results
Overexpression of orf2 increases virulence of strain S735
Introduction of a 3 kb genomic fragment from virulent
serotype 2 strain 10 increased the virulence of the weakly
virulent serotype 2 strain S735 [11], creating a hyperviru-
lent isolate (S735-pCOM1-V[10]). All pigs infected with
S735-pCOM1-V[10] died within 1 day post infection (p.i.)
and a high percentage of the pigs showed severe clinical
signs of disease (Table 1), whereas nearly all pigs infected
with the control strain S735-pCOM1 survived throughout
the experiment. Clinical indices differed significantly
(p ≤0.01) between pigs infected with S735-pCOM1-V
[10] and S735-pCOM1 (Table 1). As a control we also
tested the virulence of S735 transformed with a plasmid
containing the homologous 3 kb fragment from strain S735(S735-pCOM1-V[S735]). A high percentage of the pigs in-
fected with S735-pCOM1-V[S735] survived throughout the
experiment. In contrast pigs infected with S735-pCOM1-V
[S735] showed significantly more specific clinical signs
(p ≤0.01) than pigs infected with S735-pCOM1 (Table 1),
although differences in clinical indices for fever and non-
specific symptoms were not significantly different between
the groups (p = 0.06). Thus the increased copy number of
V[S735] in S735, due to introduction of plasmid pCOM1-V
[S735] increased specific clinical signs of S. suis. Neverthe-
less, the specific and non-specific clinical signs due to por-
cine infection with S735-pCOM1-V[10] (p ≤0.01) were
significantly increased compared to pigs infected with
S735-pCOM1-V[S735], demonstrating that the introduc-
tion of V[10] in strain S735 increased the virulence more
than introduction of V[S735]. This result indicated that
hypervirulence of strain S735 pCOM-1-V[10] might be due
to the different nucleotide polymorphisms in V[10] com-
pared to V[S735].
To determine whether V[10] alone could increase the
virulence of an otherwise avirulent S. suis strain, pCOM1-
V[10] was introduced into the avirulent serotype 2 strain
T15 to generate strain T15 pCOM1-V[10]. All piglets in-
fected with T15-pCOM1-V[10] survived throughout the
experiment (14 d p.i.), some piglets did show mild clinical
signs including fever and specific symptoms (Table 1). Al-
though wild-type isolate T15 was not included into this
study, clinical signs or fever have not been previously re-
ported in piglets intranasally infected with this avirulent
serotype 2 isolate [12,13]. Based on this results we tenta-
tively concluded that the introduction of pCOM1-V[10]
might increase the virulence of strain T15 slightly, al-
though the effect was smaller than that observed in strain
S735, and could also be due to intravenous inoculation.
Obviously, the genetic background of a strain determines
whether introduction of V[10] suffices to increase the viru-
lence tremendously.
To determine if the complete orf2-folC-operon was re-
quired for the observed increase in virulence, both genes
of the operon from strain 10 and its cognate promoter
were introduced separately into strain S735 to generate
strains S735-pCOM1-orf2[10] and S735-pCOM1-folC
[10]. Virulence of these isolates was determined in an
experimental infection in piglets, using S735-pCOM1-V
[10] and S735-pCOM1 as controls. Table 1 shows that
pigs infected with S735-pCOM1-V[10] or with S735-
pCOM1-orf2[10] died within one day p.i. with severe
clinical signs. Infected pigs developed toxic shock-like
syndrome that was not observed using wild-type strain
10 in experimental infections, implying fragments V[10]
and orf2[10] increased virulence of S735 yielding more
virulent isolates than strain 10 [3]. Both specific and
non-specific symptoms were significantly increased
(p <0.01) in pigs infected with S735-pCOM1-V[10] or with
Table 1 Virulence of complemented S. suis strains in germfree piglets; all strains contained a plasmid (pCOM1) with or
without insert
Clinical index of the
group
No. of pigs in which



















S735-pCOM1-V[10] 4 106 100 1 100 100** 100** 38* 4 4 4
S735-pCOM1-orf2[10] 4 106 100 1 100 100** 66** 29 4 4 4
S735-pCOM1-folC[10] 4 106 0 11 0 4 21 1 0 0 0
S735-pCOM1 4 106 0 11 0 0 21 5 0 0 0
S735-pCOM1-V[10]f 5 106 100 1 100 100** 100** 60* 5 5 5
S735-pCOM1-V[S735]f 5 106 20 15 100 43** 38 25 1 1 1
S735-pCOM1f 5 106 20 16 60 14 11 12 1 0 0
T15-pCOM1-V[10] 5 106 0 14 16 4 16 13 1 1 1
V[10]/V[S735]: original 3 kb fragment from strain 10 or strain S735 that was selected from library; orf2[10]: orf2 from V[10]; folC[10]: orf3 from V[10]encoding
dihydrofolate synthase.
aPercentage of pigs that died due to infection or had to be killed for animal welfare reasons.
bPercentage of pigs with specific symptoms.
cPercentage of observations for the experimental group in which specific symptoms (ataxia, lameness of a least one joint and/or stillness) were observed.
dPercentage of observations for the experimental group in which non-specific symptoms (inappetite and/or depression) were observed.
ePercentage of observations for the experimental group of a body temperature of >40°C.
fPrevious experiments (Smith et al., 2001) were re-analyzed to allow for statistical comparison between experiments, this re-analysis required new stringent
definitions of specific and aspecific symptoms as indicated in materials and methods.
*p ≤0.05 compared to S735-pCOM1.
**p ≤0.01 compared to S735-pCOM1.
gSerosae are defined as peritoneum, pericardium or pleura.
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(Table 1). Bacteriological examination showed that
CNS, serosae and joints were colonized by high CFU of
S. suis. In contrast pigs infected with S735-pCOM1-
folC[10] or S735-pCOM1 lived throughout the experi-
ment (11 days p.i.) showing mild symptoms of infection,
like fever. No significant differences in clinical outcome
were observed between pigs infected with S735-pCOM1-
folC[10] and with S735-pCOM1. This clearly demonstrates
that introduction of folC[10] does not increase the viru-
lence of strain S735, whereas introduction of V[10] and
orf2[10] increased the virulence of strain S735. Therefore,
we concluded that the observed increased virulence of
S735-pCOM1-V[10] compared to S735-pCOM1 was at-
tributed to introduction of orf2[10].
Innate immune response of porcine PBMCs
As clinical signs of S. suis strains S735-pCOM1-V[10]
and S735-pCOM1-orf2[10] were severe, it was hypothe-
sized that introduction of orf2 might exacerbate the in-
nate inflammatory response to S. suis contributing to the
host pathology and symptoms. To test this hypothesis,
immune responses of porcine PBMCs to S735-pCOM1-
orf2[10] and S735-pCOM1 were compared in vitro. Gene
expression levels of innate immune genes of PBMCs were
determined after incubation with S. suis isolates as a func-
tion of time (2, 4 and 6 h p.i.) using qPCR. Both S735-
pCOM1 and S735-pCOM1-orf2[10] induced high geneexpression of pro-inflammatory cytokine IL-1-β (170-
fold) and chemokine IL-8 (130-fold) compared to controls
whereas relatively low gene expression of pro-inflammatory
IL-6 (15-fold), anti-inflammatory IL-10 (8-fold), and TNF-α
(9-fold) and IFN-γ (4-fold) was induced by both isolates
(Figure 1). The transcript levels peaked at 4 h p.i. for all
genes tested except for IL-12 which was not expressed in
response to S. suis during the incubation time of our ex-
periment (Figure 1). There were no significant differences
between the two isolates in the expression levels of any of
the tested immune genes. These data suggest that the ob-
served increased virulence of S735-pCOM1-orf2[10] in pig-
lets compared to S735-pCOM1 is probably not due to
differences in the host innate responses to this strain.
A promoter SNP leads to differential expression of the
orf2/folc operon
Sequence analysis of the putative promoter of orf2 re-
vealed a difference at one nucleotide position in the −35
region of the putative promoter in strain 10 (TGGACA)
compared to strain S735 (TGGTCA) [11]. The effect of
this SNP on expression levels of orf2 and folC in strains
10 and S735 was determined using qPCR analysis. Sig-
nificantly higher levels of expression of orf2 as well as
folC were observed in strain 10 compared to strain S735
(Figure 2A). This clearly indicates that the SNP in the −35
region of the putative promoter affects the transcription of























































































































































Figure 1 (See legend on next page.)
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Figure 1 Innate immune response of porcine PBMCs to S. suis isolates. Porcine PBMCs were incubated with S. suis strains S735-pCOM1 and
S735-pCOM1-orf2[10] at an MOI of 1. Gene expression of IL-1-β (panel A), IL-6 (panel B), IL-8 (panel C), IL-10 (panel D), TNF-α (panel E), IFN-γ
(panel F), and IL-12 (panel G) was determined using qPCR after 2 h (white bars), 4 h (hatched bars) and 6 h (black bars) of stimulation. Relative
expression was determined by expressing the amount of target gene relative to a housekeeping gene. LPS: lipopolysaccharide; PBS: phosphate
buffered saline. Each bar represents two individual experiments each performed in duplo. Error bars represent standard error of the mean. Significance
was determined by 2-way ANOVA analysis, only significant differences between PBS treatment, S735-pCOM1 and S735-pCOM1-orf2[10] are indicated,
*p <0.05; **p <0.01; ***p <0.001.
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transcribing orf2 and folC in an operon. Moreover, intro-
duction of pCOM1-orf2[10] into S735 increased expression
of orf2 31-fold compared to introduction of pCOM1,
whereas introduction of pCOM1-orf2[S735] increased ex-
pression of orf2 only 5-fold (Figure 2B). As expected ex-
pression levels of folC were similar for both recombinant
strains (Figure 2B). To confirm that the identified SNP in
the −35 region of the promoter is responsible for the differ-
ences in transcription of orf2 in strains S735 and 10 the
TGGTCA of orf2[S735] was mutated to TGGACA as
found in the promoter of orf2[10] (yielding strain S735-
pCOM1-orf2[S735][t488a]. Transcript levels of orf2 in
S735-pCOM1-orf2[S735][t488a] were shown to be similar
to that of strain S735-pCOM1-orf2[10] and four-fold
higher than that of strain S735-pCOM1-orf2[S735] in dif-
ferent growth phases (Figure 2C). Both promoters are most
active early in the growth phase of S. suis when grown in
Todd Hewitt broth (Figure 2C). Together, these results
clearly demonstrate that in strain 10, the promoter up-
stream of orf2-folC-operon is stronger than the promoter
upstream of this operon in strain S735, due to an SNP in
the −35 region.
Sequence analysis of the-35 region of the orf2/folC promoter
and orf2 sequence in different strains and serotypes of
S. suis
To determine whether the SNP linked to increased expres-
sion of orf2-folC operon was associated with particular
clonal types or serotypes of S. suis the promoter regions of
a large collection of isolates were sequenced (Table 2 &
Additional file 1: Table S1). All isolates used were recently
characterized and typed by CGH and MLST [14]. Based
on the sequence data obtained, isolates could be divided in
two main groups (Table 2 & Additional file 1: Table S1).
The strong −35 promoter region was exclusively found in
serotype 1 and 2 isolates that belonged to CGH cluster A
and MLST clonal complex 1 and that expressed the EF-
protein. The SNP associated with lower promoter activity
was found in serotype 7 and 9 isolates belonging to CGH
group B (except for two), which are all negative for the ex-
pression of EF, as well as in weakly virulent isolates of
serotype 2 belonging to CGH group A/Clonal Complex 1
(CC1) that were positive for the expression of the larger
form of EF protein (EF*). There were two exceptions;serotype 7 isolate (C126), that belongs to CC1 but does
not express the EF-protein contained the SNP linked to
higher promoter activity and serotype 7 isolate (7711)
which had a different −35 promoter sequence (TTGTCA)
for which the promoter strength is undetermined. In con-
clusion, only CC1 isolates expressing EF protein (and 1
serotype 7 isolate) contain the SNP linked to strong pro-
moter activity. As isolates of this combination of pheno-
type and genotype are strongly correlated with virulence
[14,15], upstream of orf2-folC-operon is associated with
virulent isolates of S. suis.
Besides the correlation between promoter strength and
virulence, we also looked for an association between amino
acid sequence of ORF2 and virulence. Sequence analysis of
the orf2-folC-operon of wild type strains 10 and S735 re-
vealed several SNPs throughout the sequence [11]. A com-
parison of ORF2 protein sequences in different isolates
revealed more heterogeneity. However, ORF2 protein se-
quence of all serotype 2 MRP+EF+ isolates were identical
to the sequence of ORF2 in strain 10, besides some vari-
ation in the predicted start site of the proteins. Clustering
of protein sequences revealed three groups of ORF2 se-
quences, indicated with cluster 1, 2 and 3 in Figure 3.
Within cluster 1, two subclusters could be identified: clus-
ter 1A and 1B. Cluster 1A contained strains with an ORF2
sequence that was identical to strain 10; these isolates
seem to be associated with virulence. All of the character-
ized isolates within cluster 1A belong to CC1 and express
EF protein. Furthermore, all isolates containing the stron-
ger promoter belonged to this group. Cluster 1B contained
two isolates, a Chinese serotype 7 isolate and a serotype 2
MRP−EF− isolate (89–1591), with respectively one and two
amino acid substitutions in ORF2 compared to ORF2 of
strain 10. The observation that 89–1591 clusters with a
serotype 7 isolate, instead of with the other serotype 2
MRP−EF− isolates, adds to the speculation that strain 89–
1591 is more similar to serotype 7 isolates than to other
MRP−EF− isolates as was also suggested in our CGH study
[14]. Within cluster 2, three subclusters could be identi-
fied: cluster 2B contained avirulent serotype 2 isolates that
were MRP−EF−, cluster 2C contained weakly virulent
MRP+EF− isolates including S735, and cluster 2A con-
tained 1 serotype 3 isolate with unknown virulence. Within
these subclusters amino acid sequences are identical, the























































































Figure 2 (See legend on next page.)
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Figure 2 Expression levels of orf2 and folC in S. suis wild-type isolates and mutants. Expression level of orf2 and folC in S. suis wild-type
isolates strain 10 (black bars) and S735 (white bars) grown exponentially in Todd Hewitt (panel A); and in strain S735 complemented with empty
control plasmid pCOM1 (black bars), with orf2[10] (white bars) or with orf2[S735] (hatched bars) grown exponentially in Todd Hewitt (panel B).
Expression level of orf2 in S735 complemented with orf2[10], orf2[S735] and orf2[S735][t488a] after growing in Todd Hewitt until early exponential
phase (EEP) (white bars), exponential phase (EP) (small hatched bars), late exponential phase (LEP) (large hatched bars) and stationary phase (SP)
(black bars) (panel C). Expression levels were determined using qPCR and expressed as relative expression to housekeeping gene recA. The
experiments were performed in triplicate, error bars indicate standard error of the mean. Significance was determined by paired t-tests. *p <0.05;
**p <0.01.
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type 9 isolates from different geographical locations, in-
cluding the reference strain 5218. In conclusion, isolates
that are associated with virulence have a strong promoter
and an identical protein sequence of ORF2, whereas less
virulent isolates have a weaker promoter and a different
protein sequence. The relevance of the heterogenic amino
acid composition of ORF2 is unknown, it could interfere
with function or folding of ORF2.
Discussion
In this study we showed that introduction of the orf2-gene
(ssu0135 in P1/7) of the orf2-folC-operon from strain 10
increased the virulence of weakly virulent strain S735,
thereby creating a hypervirulent isolate. The increased
virulence of S735-pCOM1-V[10] was shown to be cor-
related with increased expression of orf2 due to the
presence of a stronger promoter in strain 10 compared
to strain S735. The promoter of the orf2-folC-operon
differed at single nucleotide position close to the
predicted −35 region, implicating that one SNP at a
crucial position can increase the virulence of S. suisTable 2 Sequence analysis of the −35 region of the orf2/folC
Phenotype
Serotype MRP2 EF3 CGH cluster4 Clo
1 - - B 13
1 S + A 1
2 - - B 16/
2 + - B 28
2 + * A 1
2 - * A 1
2 + + A 1
7 - - B 29/
9 - - B 16
9 * - B 16
9 + - B 16
1S. suis isolates were described in de Greeff et al. [14].
2*indicates an higher molecular weight form of MRP; s indicates a lower molecular
3*indicates an higher molecular weight form of EF.
4All isolates were genotyped using Comparative Genome Hybridization (CGH) [14].
5This isolate belongs to clonal complex 1.
“-” indicates absence of the protein; “+” indicates presence of the protein.tremendously. The stronger promoter was only present
in serotype 1 and 2 isolates belonging to MLST clonal
complex 1 that express EF protein, suggesting an asso-
ciation between the strong promoter (and thus higher
expression of orf2) and virulence.
Introduction of heterologous orf2[10] into weakly viru-
lent S. suis strain S735 and subsequent infection of pigs
with this strain resulted in unusually rapid development of
toxic shock-like syndrome and severe clinical signs within
1 day p.i , which resulted in the pigs being euthanized for
ethical reasons. Introduction of the homologous fragment
containing the intact operon from strain S735 also in-
creased the virulence of the resulting isolate S735-
pCOM1-V[S735] significantly compared to the control iso-
late S735-pCOM1 but the virulence was significantly less
that than that of strain S735 pCOM1-V[10]. The virulence
of the isolates was correlated with gene expression level of
orf2. The −35 sequence of the promoter region of the folC-
orf2-operon in strain 10 (TGGACA) deviated from the σ70
consensus promoter (TTGACA) at 1 position, and induced
higher expression of both orf2 and folC than the −35 se-
quence of the promoter region of the folC-orf2-operon inpromoter among various S. suis isolates and serotypes1
−35 promoter sequence (5′- 3′)



















Figure 3 Alignment of Orf2 sequences of different S. suis isolates as available in the database. Phylogenetic tree of ORF2 sequences
available in the database. Three different clusters are indicated in dotted boxes, sub-clusters are also indicated. Virulence of strains is indicated
using V, AV, WV (virulent, weakly virulent, avirulent), as well as the host where virulence was determined indicatd with p or h (pigs, humans).
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sus at 2 positions. Introduction of homologous V[S735]
preceded by the weaker S735 promoter into strain S735,
increased the expression level of orf2 5 fold and signifi-
cantly increased the virulence of the isolate compared to
the control S735-pCOM1. Hypervirulence, however, is only
achieved when multiple copies of either V[10] or orf2[10]
both preceded by the stronger promoter were present in
strain S735 This demonstrates that increase of heterol-
ogous or homologous expression of orf2 in strain S735, in-
creased the virulence of S735. A similar effect has been
observed for the suilysin gene (sly), where 2 SNPs in the
promoter region of sly were detected, and suggested to be
associated with more virulent isolates [16]. In S. suis a
slight increase of virulence occurred after introducing V
[10] into avirulent strain T15 although the effect was less
pronounced than in strain S735. This suggests that in-
creased heterologous orf2[10] expression in strain T15
might increase the virulence, but the completely different
genetic background of strain T15 [14,17] probably prohib-
ited a more pronounced increase of virulence of this strain.
In conclusion, increased heterologous or homologousexpression of orf2 in either strain S735 or strain T15 was
correlated with increased virulence.
Unfortunately, orf2 did not show homology to any
known sequences in the database, so it was not possible
to predict the function of orf2, and its role in S. suis
pathogenesis. Based on hydrophobicity plots [11], ORF2
was predicted to be localized in the membrane, and
could therefore interact with the host during infection.
The host innate response to the hypervirulent isolate was
studied in vitro in PBMCs. A strong pro-inflammatory im-
mune response was induced in PBMCs that peaked 4 h p.i.
both after incubation with the hypervirulent isolate as well
as with the control isolate (S735-pCOM1). Similar pro-
inflammatory host responses to S. suis were described for
alveolar macrophages [18], brain microvascular cells [19],
monocytes [20] and choroid plexus cells [21], suggesting
the hypervirulent isolate induced a similar innate response
to other S. suis isolates in vitro. This observation needs to
be confirmed in vivo.
In post-mortem bacteriology of piglets infected with the
hypervirulent isolate, the organs were found to be colo-
nized by extremely large numbers of S. suis. This result
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in vivo, whereas in vitro the hypervirulent isolate S735-
pCOM1-orf2[10] showed a slightly decreased growth rate
compared to S735-pCOM1 (data not shown). It could
have been expected that the high numbers of bacteria
present within 24 h in organs of pigs infected with S735-
pCOM1-orf2[10], resulted in a strong proinflammatory re-
sponses, that could ultimately result in the observed toxic
shock-like syndrome. However, as in vitro measurements
did not show any differences in host responses between
S735-pCOM1-orf2[10] and S735-pCOM1 , it is more likely
that introduction of orf2 into strain S735 is responsible for
rapid growth and/or spreading of the bacteria in the host,
and is not directly involved in a changed host response.
This suggestion could be further substantiated by the
in vitro expression studies that showed that orf2 expres-
sion is highest in the early exponential growth phase.
Although the in vitro kinetics of gene expression do not
necessarily reflect the in vivo kinetics, it is plausible
that orf2 expression is regulated under in vivo condi-
tions as well. This would suggest that the advantage of
introduction of orf2 into strain S735 is inducible during
the infection process, leading to more efficient breaking
of host defence barriers, or to an increased growth rate
as was already suggested by the large bacterial load. Re-
cently, a gene homologous to ssu0135 was annotated as
folate transporter folT in S. suis strain SC070731. This
suggests that the whole V[10] operon is involved in fol-
ate metabolism. It is known that folate is essential for
all living organism including bacteria. Our results
would suggest that overexpression of genes involved in
folate metabolism would be beneficial for growth and
virulence in vivo.
In this study, we demonstrated that the stronger pro-
moter was present in all virulent or highly virulent S. suis
isolates that expressed EF protein that were included in
our study, highlighting a correlation between high orf2
expression and virulence. Conversely, the weaker pro-
moter was present in isolates known to be weakly
pathogenic or non-pathogenic. There were some excep-
tions. A serotype 7 isolate (7711) was shown to have a
different promoter that deviated from the σ70 consen-
sus promoter at one position, like the strong promoter.
Strength of this promoter is unknown. Another sero-
type 7 isolate (C126) contained the stronger promoter.
This isolate belonged to MLST clonal complex 1, that
strictly contains virulent S. suis isolates [15] and was
isolated from the joints of a lame pig. Based on these ob-
servations, it could be speculated that this isolate is more
virulent than other serotype 7 isolates. Finally, the serotype
1 reference strain (5482) contained the weak promoter
despite being virulent. However, this isolate was already
shown not to be a good representative of serotype 1 iso-
lates [14].Conclusion
Taken together, the difference in expression level of orf2
due to different promoter sequences could be respon-
sible for the observed difference in virulence. However,
we cannot exclude the possibility that the amino acid
substitutions of ORF2 also affect function or effect of
the ORF2 proteins of S. suis strains. In conclusion, the
presence of a strong promoter in the −35 region of the
orf2-folC-operon is associated with virulence. Further re-
search on the biological function of orf2may identify novel
targets for vaccination or therapy of S. suis infections.
Methods
Bacterial strains and plasmids
S. suis isolates were grown in Todd-Hewitt broth (Oxoid,
London, United Kingdom) and plated on Columbia
blood base agar plates (Oxoid) containing 6% (vol/vol)
horse blood. Escherichia coli was grown in Luria Broth
and plated on Luria Broth containing 1.5% (wt/vol) agar.
If required, erythomycin was added at 1 μg ml−1 for S.
suis and at 200 μg ml−1 for E. coli. S. suis strain S735
complemented with a plasmid containing a 3 kb gen-
omic fragment derived from strain 10 (S735-pCOM1-V
[10]) and the other S. suis strains used in this study have
been previously described [11,14] (Figure 4).
Complementation of S. suis strain S735
S735 was complemented with plasmid pCOM1 contain-
ing one of the two ORFs in the V[10] operon (i.e. orf2
[10], or folC[10]) preceded by the putative promoter re-
gion of the operon from strain 10 or with plasmid
pCOM1 containing orf2 and the cognate upstream pro-
moter from strain S735 (orf2[S735]) (Figure 4). To con-
struct these plasmids, primers with restriction sites were
designed to amplify orf2[10] or orf2[S735] (comE1 –
comE2), folC[10] (comE4 – comE6) or the promoter re-
gion of the operon (comE1 – comE3) (Table 3). The
resulting PCR products orf2[10] and orf2[S735] were
digested using restriction enzymes SacI and BamHI,
cloned into pKUN19 [22], digested with the same re-
striction enzymes and subsequently cloned into pCOM1,
yielding pCOM1-orf2[10] and pCOM1-orf2[S735], re-
spectively. The PCR amplicon of folC[10] was digested
using restriction enzymes SmaI and BamHI and cloned
into pKUN19 cleaved with the same restriction enzymes.
The PCR product comprising the promoter region of V
[10] was cloned in front of folC[10] using restriction en-
zymes SacI and SmaI. Subsequently, the complete frag-
ment of promoter V[10] – folC[10] was digested from
pKUN19 using SacI and BamHI and cloned into pCOM1
digested with the same restriction enzymes, yielding
pCOM1-folC[10]. To confirm that the fusion product of
promoter – folC[10] was transcribed, in vitro transcrip-
tion/translation was performed using 35S-methionine.
Figure 4 Constructs used in this study. V[10] depicts the clone that was identified using a complementation strategy containing two
incomplete ORFs (greyish blue arrows) and a putative operon (purple) containing orf2[10] and folC[10] preceded by the putative promoter of the
operon (for clarification only the sequence of the −35 region (TGGACA) of the putative promoter is depicted in the diagram). Constructs were
made that contained either orf2[10] or folC[10] (purple) preceded by the putative −35 region of the putative promoter region of the operon
(purple). A construct containing orf2 from strain S735 (green) with the −35 region of the putative S735 promoter (TGGTCA) (green) was made.
The same construct was mutagenized to contain the −35 region of the putative promoter sequence of strain 10 (TGGACA) (purple)
yielding orf2[735][t488a].
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was detected demonstrating that the fusion product
could be expressed and translated. All plasmids were
introduced into S. suis strain S735 by electroporation.
In addition, pCOM1-V[10] was introduced into the
avirulent serotype 2 strain T15 [3] by electroporation to
yield T15-pCOM1-V[10].
Experimental infection
Experimental infection of caesarean derived germ-free
piglets was performed as previously described [11]. Prior
to infection, germ-free status of piglets was confirmed
by plating tonsil swabs on Columbia agar plates containing
6% horse blood. Briefly, 4 or 5 one-week-old germ-free
pigs were infected intravenously with 106 colony-forming
units (CFU) of S. suis and then immediately orally ad-
ministered 40 mg kg−1 body weight of erythomycin
(erythomycin-stearate, Abbott B.V., Amstelveen, The
Netherlands) twice a day to keep selective pressure on
S. suis isolates harbouring the pCOM plasmids. In-
fected pigs were monitored twice daily for clinical signs
and tonsil swabs collected for bacteriological analysis.
Pigs were euthanized when clinical signs of arthritis,
meningitis, or sepsis were observed after infection with
S. suis. Tissue specimens of CNS, serosae and joints
were collected during necropsy, homogenized and bac-
terial cell counts were determined by plating serial dilu-
tions on Columbia agar plates containing 6% horse
blood and 1 μg ml−1 of erythomycin. To be able to com-
pare results from different animal experiments included in
this manuscript, a uniform scoring of non-specific and
specific symptoms was applied to all animal experiments.
Non-specific symptoms included inappetite and depressionthat were scored 0 (none), 0.5 (mild inapptite/depression)
or 1 (severe inapetite/depression). Specific symptoms
included lameness, central nervous system (CNS)
symptoms (locomotive disorders like cycling, or walk-
ing in circles; opistotonus; nystagmus), as well as raised
hairs, arched back (kyphosis), and shivering, since these
are all symptoms of sepsis or serositis. Based on these
observation clinical indices were calculated by dividing
the number of observations where either specific or
non-specific symptoms were observed by the total
number of observations for this parameter. This repre-
sents a percentage of observations where either specific
or non-specific symptoms were observed. Fever was de-
fined as a body temperature >40°C. ‘Mean number of
days till death’ was used as a survival parameter. Al-
though animals were euthanized after reaching humane
end points (HEP), the time between inoculation and
reaching HEPs is still indicative of severeness of infec-
tion. It is calculated by averaging the survival in days
from inoculation until death.
All animal experiments were approved by the ethical
committee of the Central Veterinary Institute of
Wageningen UR, Lelystad, The Netherlands, in accordance
with the Dutch law on animal experiments (#809.47126.04/
00/01 & #870.47126.04/01/01).
Statistical analyses were performed on clinical indices
of the groups (fever index, specific symptoms and non-
specific symptoms) using a non-parametric Kruskal–
Wallis test as there was no homogeneity of variance
among groups. In subsequent analyses all groups were
compared pairwise to the control group (S735-pCOM1)
on all three parameters, using Mann–Whitney U tests.
Differences were considered statistically significant at
Table 3 Primer sequences
Primer name Sequence 5′-3′ Target
comE1 cgagctcggaagaattggttattgcgcgtg orf2[10] – forward - SacI
comE2 cgggatcccgggggatgacctgttgcttg orf2[10] – reverse – BamHI
comE3 tcccccgggggagtcgtgtgtattcgacagcgg P-orf2-folC[10] – reverse – SmaI
comE4 tcccccgggggacaagcaacaggtcatcccc folC[10] – forward – SmaI
comE6 cgggatcccggttgaatgcccggcaagcc folC[10] – reverse - BamHI
IL-1-ß-fw ggccgccaagatataactga Porcine interleukin 1-ß
IL-1-ß-rev ggacctctgggtatggctttc Porcine interleukin 1-ß
IL-6-fw gacaaagccaccacccctaa Porcine interleukin 6
IL-6-rev ctcgttctgtgactgcagcttatc Porcine interleukin 6
IL-8-fw ttcgatgccagtgcataaata Porcine interleukin 8
IL-8-rev ctgtacaaccttctgcaccca Porcine interleukin 8
IL-10-fw gagaaactagggagcccctttg Porcine interleukin 10
IL-10-rev tggccacagctttcaagaatg Porcine interleukin 10
IL-12-fw ggagtataagaagtacagagtgg Porcine interleukin 12-p40
IL-12-rev gatgtccctgatgaagaagc Porcine interleukin 12-p40
TNF-α-fw cgcccacgttgtagccaatgt Porcine TNF-α
TNF-α-rev cagatagtcgggcaggttgatctc Porcine TNF-α
IFN-γ-fw caaagccatcagtgaactcatca Porcine interferon-γ
IFN-γ-rev tctctggccttggaacatagtct Porcine interferon-γ
Orf2-fw ctacggctggttcttctatcgaa S. suis orf2
Orf2-rev gcaatcggtgtcatgataaagg S. suis orf2
folC-fw gtttgtccgtccatcggttt S. suis polyfolylpolyglutamate synthase
Folc-rev ctggtcggtcgcatagatga S. suis polyfolylpolyglutamate synthase
RecA-fw ggtttgcaggctcgtatgatg S. suis recombinase A
RecA-rev accaaacatgacaccgacttttt S. suis recombinase A
t488a gaaaggtatagtttttagcaagtggacaaaatatatagtgtgtgatacaat Promoter orf2
t488a_antisense attgtatcacacactatatattttgtccacttgctaaaaactatacctttc Promoter orf2
Bold characters in primers for com indicated the recognition site for restriction enzymes that was added to the primers.
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Isolation and stimulation of porcine peripheral blood
mononuclear cells
Blood from 3 – 4 week old specific pathogen free (SPF)
pigs was aseptically collected and mixed with heparin
(LEO Pharma, Breda, The Netherlands) to a final concen-
tration of 5 international units (IU) ml−1 blood. Blood was
subsequently diluted 1:1 with DPBS (Invitrogen, Carlsbad,
CA, USA). Peripheral blood mononuclear cells (PBMCs)
were isolated using Leucosep tubes (Greiner bio-one,
Frickenhausen, Germany) according to manufacturer’s in-
structions. A cell suspension was generated by passage
through a 100 μm cell strainer (BD Falcon, Bedford, MA,
USA). PBMCs were washed once in DPBS containing
30 μg ml−1 penicillin, and once in RPMI 1640 (Invitrogen)
supplemented with 2% of homologous serum (derivedfrom the same donor pig as the PBMCs) and 30 μg ml−1 of
penicillin. Cells (1 ml) were seeded at a concentration of
5.106 cells per well in 24-well tissue culture plates. After
overnight incubation, cells were stimulated with 5.106 CFU
exponentially growing S. suis cells (multiplicity of infection
(MOI) = 1), with 1 μg of lipopolysaccharide as a positive
control, or with DPBS as a negative control. Antibiotics
were not washed away to increase stimulation of PBMCs
as described by Wichgers Scheur [23]. At time point 0 (be-
fore stimulation) and after 2, 4, and 6 h of stimulation, the
supernatant was removed from the PBMCs and RNA was
isolated using Nucleospin RNA II kit (Machery Nagel,
Düren, Germany) according to manufacturer’s instructions.
cDNA synthesis and quantitative PCR
RT-PCR
Two hundred ng of RNA was used to synthesize cDNA in
a reaction containing 25 ng μl−1 random primers (Promega,
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DTT (Invitrogen), 40 U RNAsin (Promega) and Super-
ScriptII Reverse Transcriptase (Invitrogen) according to
manufacturer’s instructions.
qPCR
cDNA was diluted 20 times for qPCR analysis. Primers
were designed using PrimerExpress software (Applied Bio-
systems, Foster City, CA, USA) (Table 3), except for the
porcine reference genes that were ordered at GeNorm
(Sequenom, San Diego, CA, USA). Each reaction con-
tained 12.5 pmol forward primer, 12.5 pmol reverse primer
and POWR SYBR Green PCR Master Mix (Applied Bio-
systems) according to manufacturer’s instructions. qPCR
was performed using an ABI7500 (Applied Biosystems).
GeNorm software (GeNorm) was used to determine the
most stably expressed reference genes. Of the 5 candidate
reference genes tested for porcine RNA, the transcript
amounts of ppiA and gp1 were the least variable between
the different samples. For S. suis recA was the least variable
in expression of the 6 potential reference genes (phospho-
gelycerate dehydrogenase (pgd), acetyl coA acetyltransfer-
ase (aca), mutS, glutamate dehydrogenase (gdh), gyrase B)
tested. Genorm combines expression data into a number,
representing stability of expression, where 1 represents the
most stabile gene. Stability numbers for S. suis ranged
from 1.667 for gdh to 1.217 for recA. The level of expres-
sion of these reference genes was measured to control for
variation in RNA-yield and RT-reaction conditions. In
each qPCR run a standard curve was incorporated consist-
ing of a vector containing a cloned PCR product of the tar-
get gene of that reaction. The standard curve consisted of
seven 10-fold dilutions of the control vector. In this way
both the expression level of the target gene and the ex-
pression levels of external reference genes could be calcu-
lated from a standard curve. For each reaction water was
included in place of cDNA or template as a negative con-
trol. Analysis was performed using the ABI7500 Software
(Applied Biosystems).
Sequence analysis
Sequence reactions were performed by Baseclear (Leiden,
The Netherlands).
Site-directed mutagenesis
Site directed mutagenesis was achieved using the
Quick-change II site-directed mutagenesis kit (Agilent
Technologies, La Jolla, CA, USA) according to manu-
facturer’s instructions. PCR primers were designed with
the accompanying software (Agilent Technologies)
(Table 3). Using primers t448a and t488a_antisense the
plasmid pCOM-orf2[S735] was amplified, introducing
the desired mutation that changed the −35 region of the
putative promotor region of the orf2-folC-operon of S735from 5′-TGGTCA-3′ to 5′-TGGACA-3′ (Figure 4). The
reaction mixture was digested using DpnI to inactivate the
original template vector and subsequently transformed to
XL-1-blue competent cells (Invitrogen). To exclude the
possibility of introducing PCR errors into the vector back-
bone, the insert of the plasmid (orf2[S735]) was isolated
from the template vector after digestion with restriction
enzymes BamHI and SacI and cloned into pCOM1
digested with the same restriction enzymes. The resulting
plasmid was introduced into S. suis isolate S735 by electro-
poration and transformants were selected on Columbia
agar containing 1 μg ml−1 erythomycin, yielding S735-
pCOM1-orf2[S735][t488a]. Sequencing was used to ex-
clude presence of PCR errors in the final construct.
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